Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Impact of IDH1c.315C>T Single Nucleotide Polymorphism on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

Elizabeth Corley, Moaath Mustafa Ali, Hanan Alharthy, Kathryn Kline, Danielle Sewell, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Ashkan Emadi

Blood (2021) 138 (Supplement 1): 4454.

https://doi.org/10.1182/blood-2021-151651

Published: 2021

Journal Articles

Pim Kinase Inhibitor Enhances FLT3 Inhibitor Efficacy through GSK-3β Activation and GSK-3β-Mediated Proteasomal Degradation of c-Myc

Jonelle K. Lee, Mario Scarpa, Aditi Chatterjee, Moaath Mustafa Ali, Prerna Singh, Shivani Kapoor, Rossana Trotta, Maria R. Baer

Blood (2021) 138 (Supplement 1): 1163.

https://doi.org/10.1182/blood-2021-151737

Published: 2021

Journal Articles

The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma

Forat Lutfi, MD, Ankit Kansagra, MD, Moaath Mustafa Ali, MD, Ali Bukhari, MD, Jonathan Siglin, BS, Jingsheng Yan, PhD, Santanu Samanta, MD, Noa G. Holtzman, MD, David Gottlieb, MD, Dong Won Kim, MD, Seung-Tae Lee, MD PhD, Mehmet Hakan Kocoglu, MD, Jean A. Yared, MD, Nancy M. Hardy, MD, Jason Molitoris, MD, Pranshu Mohindra, MD, Aaron P. Rapoport, MD, Saurabh Dahiya, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141231

Published: 2020

Journal Articles

Pseudo-Allogeneic CAR-T Therapy after Allogeneic Stem Cell Transplantation in Relapsed/Refractory B-Cell NHL

Jonathan Siglin, BS, Forat Lutfi, MD, Ali Bukhari, MD, Noa G. Holtzman, MD, Dong Won Kim, MD, Moaath Mustafa Ali, MD MPH, Aaron P. Rapoport, MD, Saurabh Dahiya, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-136187

Published: 2020

Journal Articles

Low Utility of the H-Score and HLH-2004 Criteria to Identify Patients with Secondary Hemophagocytic Lymphohistiocytosis after CAR-T Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Dong Won Kim, MD, Forat Lutfi, MD, Facundo Zafforoni, BS, Moaath Mustafa Ali, MD MPH, Ali Bukhari, MD, David Gottlieb, MD, Seung-Tae Lee, MD PhD, Mehmet Hakan Kocoglu, MD, Nancy M. Hardy, MD, Jean A. Yared, MD, Aaron P. Rapoport, MD, Jennie Y. Law, MD, Saurabh Dahiya, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141992

Published: 2020

Journal Articles

Patterns of Treatment and Survival in Elderly Patients with Primary CNS Lymphoma; An 11-Year Population-Based Analysis

Yazan Samhouri, MD, Moaath Mustafa Ali, MD MPH, Thejus Jayakrishnan, MBBS, Chelsea Peterson, DO, Veli Bakalov, MD, Salman Fazal, MD, Cyrus Kahn, MD, Rodney E Wegner, MD, John Lister, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137300

Published: 2020

Journal Articles

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

Moaath Mustafa Ali, MD, Basel Rouphail, MD MBA, Robert M. Dean, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH, Brad Pohlman, MD, Mitchell R. Smith, MD PhD

Blood (2015) 126 (23): 1520.

https://doi.org/10.1182/blood.V126.23.1520.1520

Published: 2015

Journal Articles

Long-Term Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Moaath Mustafa Ali, MD, Donna M Abounader, Lisa A. Rybicki, MS, Jamie Starn, RN, BSN, Christina Ferraro, RN, BSN, Victoria Winslow, RN, BSN, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Hien Liu, MD, Robert M. Dean, MD, Rabi Hanna, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Anjali Advani, MD, Navneet S. Majhail, MD MS, Ronald Sobecks, MD

Blood (2015) 126 (23): 5534.

https://doi.org/10.1182/blood.V126.23.5534.5534

Published: 2015

Journal Articles

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Moaath Mustafa Ali, MD, Donna M Abounader, Lisa A. Rybicki, MS, Melissa A Yurch, Jamie Starn, RN, BSN, Christina Ferraro, RN, BSN, Victoria Winslow, RN, BSN, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Hien Liu, MD, Robert Dean, Brian T. Hill, MD PhD, Brad Pohlman, MD, Steven Andresen, DO, Rabi Hanna, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS, Ronald Sobecks, MD

Blood (2015) 126 (23): 1920.

https://doi.org/10.1182/blood.V126.23.1920.1920

Published: 2015

NARROW

The Impact of IDH1c.315C>T Single Nucleotide Polymorphism on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

Pim Kinase Inhibitor Enhances FLT3 Inhibitor Efficacy through GSK-3β Activation and GSK-3β-Mediated Proteasomal Degradation of c-Myc

The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma

Pseudo-Allogeneic CAR-T Therapy after Allogeneic Stem Cell Transplantation in Relapsed/Refractory B-Cell NHL

Low Utility of the H-Score and HLH-2004 Criteria to Identify Patients with Secondary Hemophagocytic Lymphohistiocytosis after CAR-T Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Patterns of Treatment and Survival in Elderly Patients with Primary CNS Lymphoma; An 11-Year Population-Based Analysis

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

Long-Term Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only